| FSH/LR-RH | follicle-stimulating hormone and luteinizing hormone releasing hormone |
|---|---|
| FSHR | follicle-stimulating hormone receptor |
| FSH-RF | follicle-stimulating hormone-releasing factor |
| FSH-RH | follicle-stimulating hormone-releasing hormone |
| hCFSH | human chorionic follicle-stimulating hormone |
| GM-CSF | Granulocyte colony-stimulating factor , granulocyte-macrophage colony-stimulating factor |
|---|---|
| G-CSF | Granulocyte-Macrophage Colony-Stimulating Factor , Granulocyte Colony-Stimulating Factor |
| FCL | Follicle center lymphoma |
| FRP | Follicle regulatory protein |
| FAE | Follicle-associated epithelium |
| pain-pleasure principle | A psychoanalytic concept that, in a human's psychic functioning, he/she tends to seek pleasure and avoid pain; a term borrowed by experimental psychology to denote the same tendency of an animal in a learning situation. Synonym: pleasure principle. (05 Mar 2000) |
|---|---|
| reality principle | The concept that the pleasure principle in personality development is modified by the demands of external reality; the principle or force that compels the growing child to adapt to the demands of external reality. (05 Mar 2000) |
| receptors, colony-stimulating factor | Cell surface receptors for colony-stimulating factors, local mediators, and hormones that regulate the survival, proliferation, and differentiation of haemopoietic cells. (12 Dec 1998) |
| receptors, granulocyte-colony-stimulating factor | Receptors that bind and internalise granulocyte-colony-stimulating factor. Their mw is believed to be 150 kD. These receptors are found mainly on a subset of myelomonocytic cells. (12 Dec 1998) |
| receptors, granulocyte-macrophage colony-stimulating factor | Receptors that bind and internalise the granulocyte-macrophage stimulating factor. Their mw is believed to be 84 kD. The most mature myelomonocytic cells, specifically human neutrophils, macrophages, and eosinophils, express the highest number of affinity receptors for this growth factor. (12 Dec 1998) |
| receptors, macrophage colony-stimulating factor | Glycoproteins of mw 165 kD which are encoded by the c-fms proto-oncogene. The binding of csf-1 to its receptors activates an intrinsic tyrosine kinase activity resulting in autophosphorylation of the receptors on tyrosine, rapid receptor down-regulation, and phosphorylation of as yet unidentified physiologic substrates that initiate a mitogenic response. (12 Dec 1998) |
| Pauli's exclusion principle | The theory limiting the number of electrons in the orbit or shell of an atom; that it is not possible for any two electrons to have all four quantum numbers identical. (05 Mar 2000) |
| repetition-compulsion principle | In psychoanalysis, the impulse to redramatise or reenact earlier emotional experiences or situations. Synonym: principle of inertia. (05 Mar 2000) |
| melanocyte-stimulating hormone | <endocrinology> A releasing hormone produced in the mammalian hypophysis and related structures in lower vertebrates. Made up of _ MSH (1665D), the same as amino acids 1-13 of ACTH and _ MSH (18 amino acids, 22 in humans). Causes darkening of the skin by expansion of the melanophores but its role in mammals is unclear. Synonym: melanotropin. Acronym: MSH (22 Sep 2002) |
| melanophore-expanding principle | A polypeptide hormone secreted by the intermediate lobe of the hypophysis in humans (in neurohypophysis in certain other species) which causes dispersion of melanin by melanophores, resulting in darkening of the skin, presumably by promoting melanin synthesis; this effect is readily demonstated in some lower vertebrates, such as frogs and fish; alpha-melanotropin is an N-acetylated peptide with 13 amino acids; beta-melanotropin has 22 amino acids. Synonym: intermedin, melanocyte-stimulating hormone, melanophore-expanding principle. (05 Mar 2000) |
| granulocyte-colony-stimulating factor | <growth factor, haematology, oncology> A glycoprotein of 25 kD containing internal disulfide bonds. It induces the survival, proliferation, and differentiation of neutrophilic granulocyte precursor cells and functionally activates mature blood neutrophils. Among the family of colony-stimulating factors, G-CSF is the most potent inducer of terminal differentiation to granulocytes and macrophages of leukaemic myeloid cell lines. A protein that stimulates the growth and maturation of granulocytes. It is used to promote the recovery of the white cells following chemotherapy. See: colony-stimulating factor. Acronym: G-CSF (12 Dec 1998) |
| granulocyte-macrophage colony-stimulating factor | <growth factor, haematology, oncology> An acidic glycoprotein of mw 23 kD with internal disulfide bonds. It is produced in response to a number of inflammatory mediators by mesenchymal cells present in the haemopoietic environment and at peripheral sites of inflammation. It stimulates the production of neutrophilic granulocytes, macrophages, and mixed granulocyte-macrophage colonies from bone marrow cells and can stimulate the formation of eosinophil colonies from foetal liver progenitor cells. It also has some functional activities in mature granulocytes and macrophages. It is used to promote the recovery of the white blood cells following chemotherapy. Chemical name: Colony-stimulating factor 2 See: colony-stimulating factor. Acronym: GM-CSF (12 Dec 1998) |
| Mitrofanoff principle | Use of an isolated appendix on a vascularised pedicle as a catheterizable route of access to the bladder from the skin. Synonym: Mitrofanoff principle. Origin: eppendico-+ L. Vesica, bladder, + G. Stoma, mouth (05 Mar 2000) |
| closure principle | In psychology, the principle that when one views fragmentary stimuli forming a nearly complete figure (e.g., an incomplete rectangle) one tends to ignore the missing parts and perceive the figure as whole. See: gestalt. (05 Mar 2000) |
| colony-stimulating factor | <cell biology> A glycoprotein growth factor that regulates the differentiation of particular cells. These substances act in either paracrine or autocrine fashion on marrow cells, appear to act synergistically and can exert actions on several lines of progenitor cells, and influence end cell function. These lymphokines induce the maturation and proliferation of white blood cells from the primitive cell types present in bone marrow such as the leucocyte, macrophage and monocyte lines. These substances can also be made by recombinant DNA technology for use clinically to speed bone marrow recovery typically following chemotherapy. Acronym: CSF (18 Jul 2002) |